openPR Logo
Press release

Anti-counterfeit Pharmaceutical Packaging Market to Exhibit a Robust CAGR of 12.1% by 2026

02-28-2017 07:30 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Future Market Insights

Anti-counterfeit Pharmaceutical Packaging Market to Exhibit

Future Market Insights projects some key insights on the Global Anti-Counterfeit Pharmaceutical Packaging Market in a new report named, “Anti-counterfeit Pharmaceutical Packaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2026”. The global anti-counterfeit pharmaceutical packaging market is predicted to register a robust CAGR of more than 11.1% during the forecast period 2016-2026. The report provides in-depth information on the global anti-counterfeit pharmaceutical packaging market and talks about the global market behaviour, competitive economy, market drivers, and market width and assess the climate of the market for the next ten years.

The surge in the demand for safe packaging to destroy the nexus of illicit drugs spread across the globe is increasing. The present pharmaceutical economy is poisoned by forged medicines that are available in the market in abundance. The soaring market size of the counterfeit drugs is creating a parallel economy in the global market. The emerging threat has a rippling effect on all the stakeholders and also on the consumers. This dark underbelly of the pharmaceutical industry is crippling the growth of the market. The increasing population of counterfeiting drugs compelled the pharma manufacturers to set up a safety ring to guard them against this threat. Anti-counterfeiting packaging has the ability to unshackle the pharmaceutical industry from the clutches of counterfeit medicines. Pharma companies inducted multiple anti-counterfeit designs to stop the malice. Advanced hologram, water and barcode are mostly used as a regular restrictive measure to stop the emergence of counterfeit medicines. However, with the use of state of the art technology, the pharmaceutical manufacturers have successfully bulldozed this risk. The alarming rise in the need of the anti-counterfeit pharmaceutical packaging is a dawn of a new era. Mushrooming popularity of the Anti-Counterfeit Pharmaceutical packaging technology is affecting the global demand for the Anti-Counterfeit Pharmaceutical packaging.

The WHO and FDA’s efforts to ensure safe-conduct practices across the pharmaceutical industry value chain by integrating advanced anti-counterfeit packaging technology encouraged pharma manufacturers to explore new possibilities. This, in turn, is creating value for suppliers of anti-counterfeit packaging technology to the pharmaceutical industry. The anti-counterfeit pharmaceutical packaging market is responding with positive growth rate, which is likely to continue during the period of assessment.

Request For Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-2385

Segmentation highlights

Global anti-counterfeit pharmaceutical packaging is divided as per the usage feature (convert features, evidence and track & trace, tamper feature, divert features, forensic markers, technologies- [identification system and sterilization] and technology (security printing and graphics, RFID- [active tags, passive tags, semi-active tags], security inks and coatings, Mass Encoding-[ Barcode Application, Digital Mass Serialization, Digital Mass Encryption], Hologram, Others- [Electromagnetic, surveillance technologies]).

On the basis of usage feature, track & trace technologies segment will spike and it will account for more than US$ 2,700 Mn by the end of the prediction period, registering a high CAGR of over 12% over the assessment period. It will occupy more than 35% of the market share by the end of the period of conjecture. Covert feature segment is anticipated to follow closely and to register CAGR of little more than 12% by the end of the period of projection.

The Security Painting and Graphics technology stream of the global anti-counterfeit pharmaceutical packaging market worth in 2015 was 208.9 Mn. It will continue its growth trail and it is predicted to touch a market worth of more than US$ 7 Mn by the end of 2026, record a CAGR in excess of 11.5% during the assessment period. The section is likely to develop a cumulative $ opportunity of more than US$ 500 Mn within the assessment period.

The RFID technology is contributing significantly to the impressive growth in this segment. The Active Tags sub-segment is estimated to account for a market share of 47.5% in 2016, among all other RFID technologies. Furthermore, the sub-segment is anticipated to gain 330 BPS within the projection period.

Regional Market Projections:

The report covers the global anti-counterfeit pharmaceutical packaging market across seven key regions namely – North America, Latin America, Western Europe, Eastern Europe, Japan, Asia Pacific Excl. Japan (APEJ), and the Middle East and Africa (MEA). North America is predicted to dominate the anti-counterfeit pharmaceutical packaging market within the assessment period. Anti-counterfeit pharmaceutical packaging in North America to take a major leap within the forecast period as the active presence of major pharma companies, swelling exports and several biologics research hubs to expedite the market growth .

Send An Enquiry@ http://www.futuremarketinsights.com/askus/rep-gb-2385

Anti-counterfeit pharmaceutical packaging market will witness robust growth in the APAC market driven by increasing demand for anti-counterfeit measures in this part of the globe and the market is growing at the CAGR of 18.9 % over the assessment period. Latin America will likely be a rapidly growing market in the coming decade, registering CAGR of over 12%. The new wave of economic reforms in the MEA sector is wooing foreign investors. Africa is an embarking economy which is influencing native and international players. The anti-counterfeit pharmaceutical market in Africa and MEA is projected to stretch at a CAGR of more than 11% by the end of 2026 and the economic revolution in this part of the world will play a vital role.

Vendor insights:

The report has elaborately listed the leading anti-counterfeit pharmaceutical packaging manufacturers operating in the global anti-counterfeit pharmaceutical packaging market. , Avery Dennison Corp., Authentix, Sicpa Holdings, CFC international and Applied DNA sciences,3M trace & trace solution,Alien Technology, Digimarc Impinj Inc, ATL Security Label Systems, Sicpa Holdings.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-counterfeit Pharmaceutical Packaging Market to Exhibit a Robust CAGR of 12.1% by 2026 here

News-ID: 451437 • Views:

More Releases from Future Market Insights

Hybrid Meat Products Market Projected to Grow at 9.5% CAGR to USD 1,314.9 Million by 2035
Hybrid Meat Products Market Projected to Grow at 9.5% CAGR to USD 1,314.9 Millio …
The global Hybrid Meat Products Market is poised for remarkable growth over the next decade, with the market projected to expand from USD 530.6 million in 2025 to approximately USD 1,314.9 million by 2035, reflecting a robust CAGR of 9.5%. This surge underscores the growing appetite for protein solutions that blend traditional meat with plant-based ingredients, combining taste familiarity with sustainability and nutritional benefits. Hybrid meat products are gaining traction across
Fermented Coffee Market Set to Reach USD 766.8 Million by 2035: A Flavorful Blend of Tradition, Innovation, and Wellness
Fermented Coffee Market Set to Reach USD 766.8 Million by 2035: A Flavorful Blen …
The global fermented coffee market is brewing a new era of growth, with projections indicating a rise from USD 330.6 million in 2025 to USD 766.8 million by 2035-a remarkable CAGR of 8.8%. This forecast underscores a transformative decade for the category, driven by health-conscious consumer demand, innovative fermentation techniques, and the expansion of both established and emerging players in the global coffee landscape. Acquire the Complete Market Report - Available
Enzyme Protectants Market Forecast to Reach USD 1.51 Billion by 2035, Driven by Biologics, Sustainability, and Technological Innovation
Enzyme Protectants Market Forecast to Reach USD 1.51 Billion by 2035, Driven by …
The global enzyme protectants market is poised for remarkable growth over the next decade, with valuations expected to rise from USD 820.5 million in 2025 to approximately USD 1,511.5 million by 2035. Representing a compound annual growth rate (CAGR) of 6.3%, this surge reflects an increasing demand for solutions that maintain enzyme stability and performance across pharmaceuticals, food processing, industrial biotechnology, and research applications. Request the Full Report or Custom Research
Global Aqua Probiotic Market to reach USD 1,180.0 Million by 2035, Driven by Sustainable Aquaculture and Innovative Technologies
Global Aqua Probiotic Market to reach USD 1,180.0 Million by 2035, Driven by Sus …
The global Aqua Probiotic Market is poised for remarkable expansion over the next decade, projected to grow from USD 480.5 million in 2025 to approximately USD 1,180.0 million by 2035, registering a CAGR of 9.4%. This growth reflects the sector's evolution from niche adoption to mainstream integration, highlighting the increasing importance of probiotics in sustainable aquaculture practices worldwide. For Tailored Insights and Customization, Connect With Us Here: https://www.futuremarketinsights.com/reports/sample/rep-gb-26136 Rising demand for antibiotic-free

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the